Citigroup Inc Allogene Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 469,310 shares of ALLO stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

469,310

Previous 75,172 524.31%

Holding current value

$1.03 Million

Previous $175,000 650.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.08 - $3.5 $819,807 - $1.38 Million	394,138 Added 524.31%	469,310 $1.31 Million
Q2 2024 Aug 12, 2024	SELL	$2.23 - $4.38 $1.34 Million - $2.64 Million	-603,057 Reduced 88.92%	75,172 $175,000
Q1 2024 May 10, 2024	BUY	$2.92 - $5.63 $1.88 Million - $3.63 Million	643,905 Added 1875.96%	678,229 $3.03 Million
Q4 2023 Feb 09, 2024	SELL	$2.28 - $3.5 $694,104 - $1.07 Million	-304,432 Reduced 89.87%	34,324 $110,000
Q3 2023 Nov 09, 2023	BUY	$3.17 - $5.96 $181,932 - $342,056	57,392 Added 20.4%	338,756 $1.07 Million
Q2 2023 Aug 10, 2023	SELL	$4.53 - $6.74 $1.24 Million - $1.85 Million	-273,979 Reduced 49.34%	281,364 $1.4 Million
Q1 2023 May 11, 2023	BUY	$4.92 - $8.21 $1.04 Million - $1.73 Million	210,972 Added 61.26%	555,343 $2.74 Million
Q4 2022 Feb 09, 2023	SELL	$5.62 - $11.11 $637,409 - $1.26 Million	-113,418 Reduced 24.78%	344,371 $2.17 Million
Q3 2022 Nov 10, 2022	BUY	$10.32 - $17.28 $2.24 Million - $3.75 Million	216,824 Added 89.98%	457,789 $4.94 Million
Q2 2022 Aug 10, 2022	BUY	$6.78 - $12.28 $825,804 - $1.5 Million	121,800 Added 102.21%	240,965 $2.75 Million
Q1 2022 May 12, 2022	SELL	$7.65 - $15.29 $1.12 Million - $2.24 Million	-146,219 Reduced 55.1%	119,165 $1.09 Million
Q4 2021 Feb 10, 2022	BUY	$13.13 - $24.52 $1.82 Million - $3.4 Million	138,729 Added 109.53%	265,384 $3.96 Million
Q3 2021 Nov 10, 2021	BUY	$21.01 - $27.64 $2.66 Million - $3.5 Million	126,655 New	126,655 $3.26 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $315M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account